Vorasidenib
servier
['vorasidenib']
exciting news for patients with #idh mutant #gliomas as the phase 3 trial at shows positive results for adult and pediatric cases. the use of #vorasidenib and idh targeted therapy holds promise in treating this form of brain tumors . 
Physician-Scientist/Professor/Consultant /Entrepreneur/Genomic/Biotech/Neuropath. Board member @sanadccsa @DAEM_society  صوره البروفايل من رسومات اطفال سند🎗️